Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.99 USD | +1.08% |
|
-3.64% | -23.45% |
| 03-04 | China Merchants Initiates Boston Scientific at Buy With $88 Price Target | MT |
| 03-04 | Boston Scientific Corporation Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 09:10 AM |
| Capitalization | 108B 93.67B 84.82B 81.43B 149B 9,947B 155B 1,003B 401B 4,766B 407B 398B 17,088B | P/E ratio 2026 * |
29.8x | P/E ratio 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise value | 114B 98.58B 89.27B 85.7B 156B 10,469B 163B 1,056B 422B 5,016B 428B 419B 17,985B | EV / Sales 2026 * |
5.11x | EV / Sales 2027 * | 4.51x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +1.08% | ||
| 1 week | -3.64% | ||
| Current month | -5.02% | ||
| 1 month | -5.99% | ||
| 3 months | -25.15% | ||
| 6 months | -31.93% | ||
| Current year | -23.45% |
| 1 week | 70.75 |  | 76.68 |
| 1 month | 70.75 | | 76.87 |
| Current year | 70.75 | | 100.9 |
| 1 year | 70.75 | | 109.5 |
| 3 years | 46.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 17.13 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
John Sorenson
COO | Chief Operating Officer | 58 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 61 | 01/04/2009 |
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.07% | 1.75% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | -3.64% | -30.29% | +52.63% | 107B | |
| +1.20% | -0.25% | -1.02% | -7.26% | 190B | |
| -0.89% | -2.01% | -12.56% | +111.48% | 178B | |
| -1.33% | -3.52% | -4.07% | -20.20% | 145B | |
| -2.20% | -2.97% | -22.71% | -19.80% | 53.73B | |
| -1.56% | -2.34% | +15.15% | +2.40% | 49.5B | |
| -1.44% | -0.68% | +14.07% | +16.15% | 37.74B | |
| -2.42% | -8.11% | -9.03% | +0.97% | 36.01B | |
| -2.02% | -2.36% | -6.64% | -17.94% | 34.06B | |
| -1.08% | -2.24% | -16.71% | -3.46% | 31.3B | |
| Average | -1.04% | -2.16% | -7.38% | +11.50% | 86.27B | |
| Weighted average by Cap. | -0.46% | -1.90% | -8.44% | +23.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.29B 19.28B 17.46B 16.76B 30.57B 2,047B 31.92B 207B 82.53B 981B 83.67B 81.88B 3,517B | 24.61B 21.28B 19.27B 18.5B 33.74B 2,260B 35.23B 228B 91.1B 1,083B 92.36B 90.38B 3,882B |
| Net income | 3.6B 3.11B 2.82B 2.71B 4.94B 331B 5.15B 33.35B 13.32B 158B 13.51B 13.22B 568B | 4.3B 3.72B 3.37B 3.24B 5.9B 395B 6.16B 39.87B 15.93B 189B 16.15B 15.81B 679B |
| Net Debt | 5.68B 4.92B 4.45B 4.27B 7.79B 522B 8.14B 52.67B 21.04B 250B 21.33B 20.88B 897B | 2.79B 2.41B 2.18B 2.1B 3.83B 256B 3.99B 25.85B 10.33B 123B 10.47B 10.25B 440B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 72.99 $ | +1.08% | 12,823,721 |
| 04/03/26 | 72.21 $ | -2.22% | 15,541,715 |
| 03/03/26 | 73.85 $ | -3.11% | 16,684,887 |
| 02/03/26 | 76.22 $ | -0.82% | 11,112,104 |
| 27/02/26 | 76.85 $ | +1.45% | 21,487,740 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition